Literature DB >> 9754825

Failure of nocturnal changes in growth hormone to alter carbohydrate tolerance the following morning.

M F Nielsen1, S Dinneen, A Basu, R Basu, A Alzaid, R R Rizza.   

Abstract

To determine whether the increases in growth hormone that occur during sleep alter carbohydrate tolerance the following morning, two groups of volunteers were studied on two occasions. In one group saline alone was injected and infused (i.e. no octreotide) on one occasion and on the other octreotide was injected at 23.00 hours to inhibit endogenous growth hormone secretion followed by saline infusion to create a state of relative nocturnal growth hormone deficiency. In the other group the octreotide injection was followed on one occasion by a constant growth hormone infusion designed to maintain growth hormone concentrations at "basal" levels throughout the night whereas on the other it was followed by a constant infusion plus two supplemental growth hormone infusions given at midnight and 02.30 hours to mimic the normal nocturnal rise in growth hormone. The next morning, subjects were fed a radiolabelled mixed meal. The differences in the nocturnal growth hormone concentrations had no effect on the glucose, insulin, C-peptide and glucagon concentrations following breakfast ingestion nor did they alter postprandial rates of glucose production, disappearance or substrate oxidation. Thus, the normal nocturnal rise in growth hormone does not appear to be an important regulator of carbohydrate tolerance the following morning.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9754825     DOI: 10.1007/s001250051031

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  4 in total

1.  Physiologic concentrations of exogenously infused ghrelin reduces insulin secretion without affecting insulin sensitivity in healthy humans.

Authors:  Jenny Tong; Ronald L Prigeon; Harold W Davis; Martin Bidlingmaier; Matthias H Tschöp; David D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2013-04-15       Impact factor: 5.958

2.  Direct and indirect effects of amino acids on hepatic glucose metabolism in humans.

Authors:  M Krebs; A Brehm; M Krssak; C Anderwald; E Bernroider; P Nowotny; E Roth; V Chandramouli; B R Landau; W Waldhäusl; M Roden
Journal:  Diabetologia       Date:  2003-06-18       Impact factor: 10.122

3.  Direct effects of exendin-(9,39) and GLP-1-(9,36)amide on insulin action, β-cell function, and glucose metabolism in nondiabetic subjects.

Authors:  Matheni Sathananthan; Luca P Farrugia; John M Miles; Francesca Piccinini; Chiara Dalla Man; Alan R Zinsmeister; Claudio Cobelli; Robert A Rizza; Adrian Vella
Journal:  Diabetes       Date:  2013-04-01       Impact factor: 9.461

4.  Impaired hepatic counterregulatory response to insulin-induced hypoglycemia in hepatic denervated pigs.

Authors:  Michael Festersen Nielsen; Klaus Roelsgaard; Susanne Keiding; Kathrine Brodersen; Niels Møller; Mogens Vyberg; Hendrik Vilstrup
Journal:  J Clin Transl Endocrinol       Date:  2015-09-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.